$MED
MEDIFAST INC

2019 Q4 Form 10-Q Financial Statement

#000155837019010594 Filed on November 08, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q3
Revenue $170.6M $190.1M $139.2M
YoY Change 17.0% 36.5% 80.35%
Cost Of Revenue $42.60M $47.13M $32.04M
YoY Change 15.76% 47.1% 68.43%
Gross Profit $128.1M $142.9M $107.2M
YoY Change 17.4% 33.33% 84.25%
Gross Profit Margin 75.06% 75.2% 76.99%
Selling, General & Admin $108.5M $122.7M $89.73M
YoY Change 21.5% 36.71% 87.12%
% of Gross Profit 84.72% 85.82% 83.71%
Research & Development $900.0K $600.0K
YoY Change
% of Gross Profit 0.7% 0.42%
Depreciation & Amortization $1.200M $1.200M $800.0K
YoY Change 33.33% 50.0% -27.27%
% of Gross Profit 0.94% 0.84% 0.75%
Operating Expenses $109.3M $122.7M $89.73M
YoY Change 22.53% 36.71% 87.12%
Operating Profit $18.77M $20.26M $17.47M
YoY Change -5.65% 16.0% 70.79%
Interest Expense $200.0K $324.0K $361.0K
YoY Change -50.0% -10.25% 143.92%
% of Operating Profit 1.07% 1.6% 2.07%
Other Income/Expense, Net $0.00 $321.0K $361.0K
YoY Change -11.08% 150.69%
Pretax Income $18.98M $20.58M $17.83M
YoY Change -5.89% 15.45% 71.9%
Income Tax -$900.0K $4.681M $4.047M
% Of Pretax Income -4.74% 22.74% 22.7%
Net Earnings $19.88M $15.90M $13.78M
YoY Change 27.01% 15.39% 106.12%
Net Earnings / Revenue 11.65% 8.37% 9.9%
Basic Earnings Per Share $1.71 $1.36 $1.15
Diluted Earnings Per Share $1.66 $1.32 $1.14
COMMON SHARES
Basic Shares Outstanding 11.62M 11.73M 11.95M
Diluted Shares Outstanding 12.07M 12.10M

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $169.7M $178.1M $185.5M
YoY Change -6.99% -4.0% 93.86%
Cash & Equivalents $76.97M $81.20M $82.31M
Short-Term Investments $92.68M $96.91M $103.2M
Other Short-Term Assets $6.100M $4.800M $3.900M
YoY Change 32.61% 23.08% 62.5%
Inventory $48.77M $51.93M $43.85M
Prepaid Expenses
Receivables $1.437M $1.451M $1.017M
Other Receivables $5.200M $3.200M $0.00
Total Short-Term Assets $154.2M $158.3M $151.9M
YoY Change 5.93% 4.2% 31.77%
LONG-TERM ASSETS
Property, Plant & Equipment $26.04M $26.25M $18.76M
YoY Change 31.86% 39.91% -0.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $353.0K $453.0K $1.400M
YoY Change -70.16% -67.64% 250.0%
Total Long-Term Assets $40.50M $40.28M $22.52M
YoY Change 69.39% 78.91% 17.27%
TOTAL ASSETS
Total Short-Term Assets $154.2M $158.3M $151.9M
Total Long-Term Assets $40.50M $40.28M $22.52M
Total Assets $194.7M $198.6M $174.4M
YoY Change 14.89% 13.84% 29.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $76.20M $75.00M $62.80M
YoY Change 26.37% 19.43% 138.78%
Accrued Expenses $3.200M $2.500M
YoY Change
Deferred Revenue $4.333M
YoY Change 54.92%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $79.39M $77.52M $62.81M
YoY Change 31.6% 23.43% 138.81%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $10.40M $9.900M
YoY Change
Total Long-Term Liabilities $10.40M $9.900M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $79.39M $77.52M $62.81M
Total Long-Term Liabilities $10.40M $9.900M $0.00
Total Liabilities $89.82M $87.39M $62.81M
YoY Change 48.9% 39.14% 138.81%
SHAREHOLDERS EQUITY
Retained Earnings $168.8M $162.9M $124.6M
YoY Change 28.51% 30.74%
Common Stock $12.00K $12.00K $12.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $104.8M $111.2M $111.6M
YoY Change
Total Liabilities & Shareholders Equity $194.7M $198.6M $174.4M
YoY Change 14.89% 13.84% 29.7%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q3
OPERATING ACTIVITIES
Net Income $19.88M $15.90M $13.78M
YoY Change 27.01% 15.39% 106.12%
Depreciation, Depletion And Amortization $1.200M $1.200M $800.0K
YoY Change 33.33% 50.0% -27.27%
Cash From Operating Activities $19.20M $17.90M $7.000M
YoY Change 25.49% 155.71% -44.44%
INVESTING ACTIVITIES
Capital Expenditures -$900.0K -$2.200M -$1.100M
YoY Change -47.06% 100.0% -21.43%
Acquisitions
YoY Change
Other Investing Activities $0.00 $1.300M $1.000M
YoY Change -100.0% 30.0% -433.33%
Cash From Investing Activities -$800.0K -$1.000M -$100.0K
YoY Change 100.0% 900.0% -94.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -22.50M -32.10M -5.600M
YoY Change 41.51% 473.21% 43.59%
NET CHANGE
Cash From Operating Activities 19.20M 17.90M 7.000M
Cash From Investing Activities -800.0K -1.000M -100.0K
Cash From Financing Activities -22.50M -32.10M -5.600M
Net Change In Cash -4.100M -15.20M 1.300M
YoY Change 310.0% -1269.23% -81.43%
FREE CASH FLOW
Cash From Operating Activities $19.20M $17.90M $7.000M
Capital Expenditures -$900.0K -$2.200M -$1.100M
Free Cash Flow $20.10M $20.10M $8.100M
YoY Change 18.24% 148.15% -42.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Revenues
Revenues
355159000
dei Entity Central Index Key
EntityCentralIndexKey
0000910329
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-31573
dei Entity Registrant Name
EntityRegistrantName
Medifast, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3714405
dei Entity Address Address Line1
EntityAddressAddressLine1
100 International Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Baltimore
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
21202
dei City Area Code
CityAreaCode
410
dei Local Phone Number
LocalPhoneNumber
581-8042
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
MED
dei Security Exchange Name
SecurityExchangeName
NYSE
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11615371
CY2019Q3 us-gaap Revenues
Revenues
190061000
CY2018Q3 us-gaap Revenues
Revenues
139239000
us-gaap Revenues
Revenues
543040000
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
47128000
CY2018Q3 us-gaap Cost Of Revenue
CostOfRevenue
32038000
us-gaap Cost Of Revenue
CostOfRevenue
134250000
us-gaap Cost Of Revenue
CostOfRevenue
84351000
CY2019Q3 us-gaap Gross Profit
GrossProfit
142933000
CY2018Q3 us-gaap Gross Profit
GrossProfit
107201000
us-gaap Gross Profit
GrossProfit
408790000
us-gaap Gross Profit
GrossProfit
270808000
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
122671000
CY2018Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
89734000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
336458000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
221548000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
20262000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
17467000
us-gaap Operating Income Loss
OperatingIncomeLoss
72332000
us-gaap Operating Income Loss
OperatingIncomeLoss
49260000
CY2019Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
324000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.77
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.31
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11731000
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11954000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11823000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12006000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12065000
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12097000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12174000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12112000
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.75
CY2018Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.48
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.25
CY2018Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
361000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1061000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
940000
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
178000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
321000
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
361000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1050000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1118000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
20583000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
17828000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
73382000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
50378000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4681000
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4047000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15347000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10242000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
15902000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
13781000
us-gaap Net Income Loss
NetIncomeLoss
58035000
us-gaap Net Income Loss
NetIncomeLoss
40136000
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.36
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.91
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.34
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.32
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.14
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.44
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
15902000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
13781000
us-gaap Net Income Loss
NetIncomeLoss
58035000
us-gaap Net Income Loss
NetIncomeLoss
40136000
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000
CY2018Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000
CY2019Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
18000
CY2018Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-45000
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
12207000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
246000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-104000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
16000
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-47000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
245000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-106000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15918000
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13734000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
58280000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
40030000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81196000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81364000
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1860000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
394000
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1451000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1011000
CY2019Q3 us-gaap Inventory Net
InventoryNet
51925000
CY2018Q4 us-gaap Inventory Net
InventoryNet
38888000
CY2019Q3 us-gaap Short Term Investments
ShortTermInvestments
15718000
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
19670000
CY2019Q3 us-gaap Prepaid Taxes
PrepaidTaxes
3200000
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4817000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4586000
CY2019Q3 us-gaap Assets Current
AssetsCurrent
158307000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
145519000
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26247000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19747000
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11694000
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
453000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1183000
CY2019Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1887000
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2980000
CY2019Q3 us-gaap Assets
Assets
198588000
CY2018Q4 us-gaap Assets
Assets
169429000
CY2019Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
75015000
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
60323000
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2507000
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
77522000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
60323000
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9866000
CY2019Q3 us-gaap Liabilities
Liabilities
87388000
CY2018Q4 us-gaap Liabilities
Liabilities
60323000
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12126000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12117000
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11612000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11868000
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
12000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
12000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8802000
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
72000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-173000
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
162902000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
131344000
CY2019Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
489000
CY2018Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
193000
CY2019Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
63993000
CY2018Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
30879000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
111200000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
109106000
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
198588000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
169429000
us-gaap Net Income Loss
NetIncomeLoss
58035000
us-gaap Net Income Loss
NetIncomeLoss
40136000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3363000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3519000
us-gaap Share Based Compensation
ShareBasedCompensation
3415000
us-gaap Share Based Compensation
ShareBasedCompensation
2352000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-17000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-50000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3209000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
642000
med Amortization Of Premium On Investment Securities
AmortizationOfPremiumOnInvestmentSecurities
355000
med Amortization Of Premium On Investment Securities
AmortizationOfPremiumOnInvestmentSecurities
434000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1093000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2028000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3649000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
526000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13037000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
23615000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-3200000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
2272000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
232000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-453000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-188000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-134000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
15552000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
21655000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
65109000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
45478000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
3730000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
2245000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
184000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9224000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3246000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5494000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-817000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
279000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
220000
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
289000
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
249000
us-gaap Payments Of Dividends
PaymentsOfDividends
26658000
us-gaap Payments Of Dividends
PaymentsOfDividends
17404000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
33114000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
19996000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-59782000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-37429000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-168000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7230000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
81364000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75077000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
81196000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
82307000
us-gaap Income Taxes Paid
IncomeTaxesPaid
17333000
us-gaap Income Taxes Paid
IncomeTaxesPaid
9540000
us-gaap Dividends Cash
DividendsCash
8955000
us-gaap Dividends Cash
DividendsCash
5981000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
109106000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
20750000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
990000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
269000
CY2019Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
256000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
127000
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8918000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
122068000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
21383000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
1255000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
102000
CY2019Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
9998000
CY2019Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8797000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
126023000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
15902000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
1170000
CY2019Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
33000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
16000
CY2019Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
23116000
CY2019Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8762000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
111200000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
106563000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
12222000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
805000
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
62000
CY2018Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
215000
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-84000
CY2018Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
5723000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
113630000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
14133000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
830000
CY2018Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
19996000
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
25000
CY2018Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
5759000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
102863000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
13781000
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
717000
CY2018Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
158000
CY2018Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
34000
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-47000
CY2018Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
5797000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
111641000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Reclassification -</b><span style="white-space:pre-wrap;"> Certain amounts reported for prior periods have been reclassified to be consistent with the current period presentation. No reclassification in the consolidated financial statements had a material impact on the presentation.</span></p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of Estimates</b> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.</p>
CY2019Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
12680000
CY2018Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
11156000
CY2019Q3 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
3592000
CY2018Q4 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
1563000
CY2019Q3 med Inventory Non Food Finished Goods
InventoryNonFoodFinishedGoods
5102000
CY2018Q4 med Inventory Non Food Finished Goods
InventoryNonFoodFinishedGoods
2391000
CY2019Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
33766000
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
25509000
CY2019Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3215000
CY2018Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1731000
CY2019Q3 us-gaap Inventory Net
InventoryNet
51925000
CY2018Q4 us-gaap Inventory Net
InventoryNet
38888000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
15902000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
13781000
us-gaap Net Income Loss
NetIncomeLoss
58035000
us-gaap Net Income Loss
NetIncomeLoss
40136000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11731000
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11954000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11823000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12006000
CY2019Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
334000
CY2018Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
143000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
351000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
106000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12065000
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12097000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12174000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12112000
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.36
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.91
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.34
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.32
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.77
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.31
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
26.52
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
171.68
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y4M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0264
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.3330
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0287
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
18.08
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
279000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
220000
CY2019Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1200000
CY2018Q3 us-gaap Share Based Compensation
ShareBasedCompensation
717000
us-gaap Share Based Compensation
ShareBasedCompensation
3400000
us-gaap Share Based Compensation
ShareBasedCompensation
2400000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M24D
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
12373000
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
726000
us-gaap Operating Lease Cost
OperatingLeaseCost
2100000
CY2019Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
729000
us-gaap Operating Lease Payments
OperatingLeasePayments
2121000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1490000
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.039
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
733000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2951000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2985000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2641000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1665000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
2686000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13661000
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1288000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1496000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1528000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1562000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1222000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1155000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
2582000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
9545000
CY2019Q3 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-3000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-2000
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
75000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-171000
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
72000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-173000
CY2019Q3 us-gaap Marketable Securities
MarketableSecurities
96737000
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
-10000
CY2019Q3 us-gaap Interest Receivable
InterestReceivable
167000
CY2019Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
96914000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81196000
CY2019Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
15718000
CY2018Q4 us-gaap Marketable Securities
MarketableSecurities
100990000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
236000
CY2018Q4 us-gaap Interest Receivable
InterestReceivable
280000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
101034000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81364000
CY2018Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
19670000
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0
CY2018Q3 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0

Files In Submission

Name View Source Status
0001558370-19-010594-index-headers.html Edgar Link pending
0001558370-19-010594-index.html Edgar Link pending
0001558370-19-010594.txt Edgar Link pending
0001558370-19-010594-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
med-20190930.xsd Edgar Link pending
med-20190930ex1011599b0.htm Edgar Link pending
med-20190930ex311900c28.htm Edgar Link pending
med-20190930ex31226450f.htm Edgar Link pending
med-20190930ex321eb8764.htm Edgar Link pending
med-20190930x10q.htm Edgar Link pending
med-20190930x10q_htm.xml Edgar Link completed
med-20190930_cal.xml Edgar Link unprocessable
med-20190930_def.xml Edgar Link unprocessable
med-20190930_lab.xml Edgar Link unprocessable
med-20190930_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending